Transcriptomics

Dataset Information

0

Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells


ABSTRACT: We applied high-throughput sequence to identify signaling pathways, stem cell gene signature or target genes of BMI1 that were affected by our newly development humainzed anti-ROR1 antibody (cirmtuzumab) in breast cancer patient-derived xenograft (PDX) mice model

ORGANISM(S): Homo sapiens

PROVIDER: GSE108632 | GEO | 2019/01/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA427913 | ENA
2023-03-21 | E-MTAB-11740 | biostudies-arrayexpress
2011-12-31 | E-GEOD-25830 | biostudies-arrayexpress
2023-07-05 | PXD042267 | Pride
2021-02-28 | GSE161182 | GEO
2012-02-01 | GSE31631 | GEO
2011-12-31 | GSE25830 | GEO
2017-12-13 | GSE94296 | GEO
2017-08-17 | GSE96637 | GEO
2019-09-11 | PXD009636 | Pride